Disease severity and minimal clinically important differences in clinical outcome assessments for Alzheimer's disease clinical trials JS Andrews, U Desai, NY Kirson, ML Zichlin, DE Ball, BR Matthews Alzheimer's & Dementia: Translational Research & Clinical Interventions 5 (1 …, 2019 | 222 | 2019 |
Efficacy and effectiveness of depot versus oral antipsychotics in schizophrenia: synthesizing results across different research designs NY Kirson, PJ Weiden, S Yermakov, W Huang, T Samuelson, SJ Offord, ... The Journal of clinical psychiatry 74 (6), 6018, 2013 | 220 | 2013 |
Efficacy and safety of procalcitonin guidance in patients with suspected or confirmed sepsis: a systematic review and meta-analysis I Iankova, P Thompson-Leduc, NY Kirson, B Rice, J Hey, A Krause, ... Critical care medicine 46 (5), 691-698, 2018 | 96 | 2018 |
Sources of prescription opioids among diagnosed opioid abusers A Shei, JB Rice, NY Kirson, K Bodnar, HG Birnbaum, P Holly, ... Current medical research and opinion 31 (4), 779-784, 2015 | 93 | 2015 |
The economic burden of opioid abuse: updated findings NY Kirson, LM Scarpati, CJ Enloe, AP Dincer, HG Birnbaum, TJ Mayne Journal of managed care & specialty pharmacy 23 (4), 427-445, 2017 | 89 | 2017 |
Estimating the costs of opioid abuse and dependence from an employer perspective: a retrospective analysis using administrative claims data JB Rice, NY Kirson, A Shei, AKG Cummings, K Bodnar, HG Birnbaum, ... Applied health economics and health policy 12, 435-446, 2014 | 72 | 2014 |
Medical costs of Alzheimer's disease misdiagnosis among US Medicare beneficiaries CA Hunter, NY Kirson, U Desai, AKG Cummings, DE Faries, ... Alzheimer's & Dementia 11 (8), 887-895, 2015 | 70 | 2015 |
Prevalence of pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension in the United States NY Kirson, HG Birnbaum, JI Ivanova, T Waldman, V Joish, T Williamson Current medical research and opinion 27 (9), 1763-1768, 2011 | 66 | 2011 |
The economic burden of abuse of prescription opioids: a systematic literature review from 2012 to 2017 M Reinhart, LM Scarpati, NY Kirson, C Patton, N Shak, JG Erensen Applied health economics and health policy 16, 609-632, 2018 | 63 | 2018 |
Evolving brand-name and generic drug competition may warrant a revision of the Hatch-Waxman Act HG Grabowski, M Kyle, R Mortimer, G Long, N Kirson Health Affairs 30 (11), 2157-2166, 2011 | 61 | 2011 |
Implications of early treatment among Medicaid patients with Alzheimer's disease DS Geldmacher, NY Kirson, HG Birnbaum, S Eapen, E Kantor, ... Alzheimer's & Dementia 10 (2), 214-224, 2014 | 58 | 2014 |
The economic burden of schizophrenia in the United States A Kadakia, M Catillon, Q Fan, GR Williams, JR Marden, A Anderson, ... The Journal of clinical psychiatry 83 (6), 43278, 2022 | 57 | 2022 |
Excess costs associated with patients with pulmonary arterial hypertension in a US privately insured population NY Kirson, HG Birnbaum, JI Ivanova, T Waldman, V Joish, T Williamson Applied health economics and health policy 9, 293-303, 2011 | 56 | 2011 |
Basal insulin persistence, associated factors, and outcomes after treatment initiation among people with type 2 diabetes mellitus in the US M Perez-Nieves, S Kabul, U Desai, JI Ivanova, NY Kirson, AK Cummings, ... Current Medical Research and Opinion 32 (4), 669-680, 2016 | 55 | 2016 |
Time to treatment intensification after monotherapy failure and its association with subsequent glycemic control among 93,515 patients with type 2 diabetes U Desai, NY Kirson, J Kim, K Khunti, S King, E Trieschman, M Hellstern, ... Diabetes Care 41 (10), 2096-2104, 2018 | 51 | 2018 |
Pre-diagnosis excess acute care costs in Alzheimer’s patients among a US Medicaid population DS Geldmacher, NY Kirson, HG Birnbaum, S Eapen, E Kantor, ... Applied health economics and health policy 11, 407-413, 2013 | 45 | 2013 |
Estimating the health care burden of prescription opioid abuse in five European countries A Shei, M Hirst, NY Kirson, CJ Enloe, HG Birnbaum, WCN Dunlop Clinicoeconomics and outcomes research, 477-488, 2015 | 44 | 2015 |
Medical cost savings associated with an extended-release opioid with abuse-deterrent technology in the US LF Rossiter, NY Kirson, A Shei, AG White, HG Birnbaum, R Ben-Joseph, ... Journal of Medical Economics 17 (4), 279-287, 2014 | 44 | 2014 |
Mild traumatic brain injury in the United States: demographics, brain imaging procedures, health-care utilization and costs V Pavlov, P Thompson-Leduc, L Zimmer, J Wen, J Shea, H Beyhaghi, ... Brain injury 33 (9), 1151-1157, 2019 | 42 | 2019 |
One‐year effect of the Medicare annual wellness visit on detection of cognitive impairment: a cohort study NR Fowler, NL Campbell, GM Pohl, LM Munsie, NY Kirson, U Desai, ... Journal of the American Geriatrics Society 66 (5), 969-975, 2018 | 41 | 2018 |